Industry: Service & Software
Published Date: 2024-04-16
Pages: 129 Pages
Report ld: 2915662
Request Sample
Customized Report
Market Analysis and Insights: Global Personalized Medicine (PM) Solution Market
The global Personalized Medicine (PM) Solution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Personalized Medicine (PM) Solution market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Personalized Medicine (PM) Solution, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Personalized Medicine (PM) Solution, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Personalized Medicine (PM) Solution revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Personalized Medicine (PM) Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Personalized Medicine (PM) Solution revenue, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine (PM) Solution Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Personalized Diagnostics
1.2.3 Personalized Therapies
1.2.4 Personalized Nutrition & Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicine (PM) Solution Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine (PM) Solution Market Perspective (2019-2030)
2.2 Global Personalized Medicine (PM) Solution Growth Trends by Region
2.2.1 Personalized Medicine (PM) Solution Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Personalized Medicine (PM) Solution Historic Market Size by Region (2019-2024)
2.2.3 Personalized Medicine (PM) Solution Forecasted Market Size by Region (2025-2030)
2.3 Personalized Medicine (PM) Solution Market Dynamics
2.3.1 Personalized Medicine (PM) Solution Industry Trends
2.3.2 Personalized Medicine (PM) Solution Market Drivers
2.3.3 Personalized Medicine (PM) Solution Market Challenges
2.3.4 Personalized Medicine (PM) Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Personalized Medicine (PM) Solution by Players
3.1.1 Global Personalized Medicine (PM) Solution Revenue by Players (2019-2024)
3.1.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Players (2019-2024)
3.2 Global Personalized Medicine (PM) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Personalized Medicine (PM) Solution, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Personalized Medicine (PM) Solution Market Concentration Ratio
3.4.1 Global Personalized Medicine (PM) Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine (PM) Solution Revenue in 2023
3.5 Global Key Players of Personalized Medicine (PM) Solution Head office and Area Served
3.6 Global Key Players of Personalized Medicine (PM) Solution, Product and Application
3.7 Global Key Players of Personalized Medicine (PM) Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine (PM) Solution Breakdown Data by Type
4.1 Global Personalized Medicine (PM) Solution Historic Market Size by Type (2019-2024)
4.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Type (2025-2030)
5 Personalized Medicine (PM) Solution Breakdown Data by Application
5.1 Global Personalized Medicine (PM) Solution Historic Market Size by Application (2019-2024)
5.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Personalized Medicine (PM) Solution Market Size (2019-2030)
6.2 North America Personalized Medicine (PM) Solution Market Size by Type
6.2.1 North America Personalized Medicine (PM) Solution Market Size by Type (2019-2024)
6.2.2 North America Personalized Medicine (PM) Solution Market Size by Type (2025-2030)
6.2.3 North America Personalized Medicine (PM) Solution Market Share by Type (2019-2030)
6.3 North America Personalized Medicine (PM) Solution Market Size by Application
6.3.1 North America Personalized Medicine (PM) Solution Market Size by Application (2019-2024)
6.3.2 North America Personalized Medicine (PM) Solution Market Size by Application (2025-2030)
6.3.3 North America Personalized Medicine (PM) Solution Market Share by Application (2019-2030)
6.4 North America Personalized Medicine (PM) Solution Market Size by Country
6.4.1 North America Personalized Medicine (PM) Solution Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Personalized Medicine (PM) Solution Market Size by Country (2019-2024)
6.4.3 North America Personalized Medicine (PM) Solution Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Personalized Medicine (PM) Solution Market Size (2019-2030)
7.2 Europe Personalized Medicine (PM) Solution Market Size by Type
7.2.1 Europe Personalized Medicine (PM) Solution Market Size by Type (2019-2024)
7.2.2 Europe Personalized Medicine (PM) Solution Market Size by Type (2025-2030)
7.2.3 Europe Personalized Medicine (PM) Solution Market Share by Type (2019-2030)
7.3 Europe Personalized Medicine (PM) Solution Market Size by Application
7.3.1 Europe Personalized Medicine (PM) Solution Market Size by Application (2019-2024)
7.3.2 Europe Personalized Medicine (PM) Solution Market Size by Application (2025-2030)
7.3.3 Europe Personalized Medicine (PM) Solution Market Share by Application (2019-2030)
7.4 Europe Personalized Medicine (PM) Solution Market Size by Country
7.4.1 Europe Personalized Medicine (PM) Solution Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Personalized Medicine (PM) Solution Market Size by Country (2019-2024)
7.4.3 Europe Personalized Medicine (PM) Solution Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Personalized Medicine (PM) Solution Market Size (2019-2030)
8.2 China Personalized Medicine (PM) Solution Market Size by Type
8.2.1 China Personalized Medicine (PM) Solution Market Size by Type (2019-2024)
8.2.2 China Personalized Medicine (PM) Solution Market Size by Type (2025-2030)
8.2.3 China Personalized Medicine (PM) Solution Market Share by Type (2019-2030)
8.3 China Personalized Medicine (PM) Solution Market Size by Application
8.3.1 China Personalized Medicine (PM) Solution Market Size by Application (2019-2024)
8.3.2 China Personalized Medicine (PM) Solution Market Size by Application (2025-2030)
8.3.3 China Personalized Medicine (PM) Solution Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Personalized Medicine (PM) Solution Market Size (2019-2030)
9.2 Asia Personalized Medicine (PM) Solution Market Size by Type
9.2.1 Asia Personalized Medicine (PM) Solution Market Size by Type (2019-2024)
9.2.2 Asia Personalized Medicine (PM) Solution Market Size by Type (2025-2030)
9.2.3 Asia Personalized Medicine (PM) Solution Market Share by Type (2019-2030)
9.3 Asia Personalized Medicine (PM) Solution Market Size by Application
9.3.1 Asia Personalized Medicine (PM) Solution Market Size by Application (2019-2024)
9.3.2 Asia Personalized Medicine (PM) Solution Market Size by Application (2025-2030)
9.3.3 Asia Personalized Medicine (PM) Solution Market Share by Application (2019-2030)
9.4 Asia Personalized Medicine (PM) Solution Market Size by Region
9.4.1 Asia Personalized Medicine (PM) Solution Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Personalized Medicine (PM) Solution Market Size by Region (2019-2024)
9.4.3 Asia Personalized Medicine (PM) Solution Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Type
10.2.1 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Application
10.3.1 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Country
10.4.1 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Personalized Medicine (PM) Solution Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 2bPrecise
11.1.1 2bPrecise Company Details
11.1.2 2bPrecise Business Overview
11.1.3 2bPrecise Personalized Medicine (PM) Solution Introduction
11.1.4 2bPrecise Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.1.5 2bPrecise Recent Developments
11.2 OneOme
11.2.1 OneOme Company Details
11.2.2 OneOme Business Overview
11.2.3 OneOme Personalized Medicine (PM) Solution Introduction
11.2.4 OneOme Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.2.5 OneOme Recent Developments
11.3 TIGAR Health- IR2Dx
11.3.1 TIGAR Health- IR2Dx Company Details
11.3.2 TIGAR Health- IR2Dx Business Overview
11.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Introduction
11.3.4 TIGAR Health- IR2Dx Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.3.5 TIGAR Health- IR2Dx Recent Developments
11.4 Kailos Genetics
11.4.1 Kailos Genetics Company Details
11.4.2 Kailos Genetics Business Overview
11.4.3 Kailos Genetics Personalized Medicine (PM) Solution Introduction
11.4.4 Kailos Genetics Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.4.5 Kailos Genetics Recent Developments
11.5 Syapse Inc
11.5.1 Syapse Inc Company Details
11.5.2 Syapse Inc Business Overview
11.5.3 Syapse Inc Personalized Medicine (PM) Solution Introduction
11.5.4 Syapse Inc Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.5.5 Syapse Inc Recent Developments
11.6 Karius
11.6.1 Karius Company Details
11.6.2 Karius Business Overview
11.6.3 Karius Personalized Medicine (PM) Solution Introduction
11.6.4 Karius Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.6.5 Karius Recent Developments
11.7 Astarte Medical
11.7.1 Astarte Medical Company Details
11.7.2 Astarte Medical Business Overview
11.7.3 Astarte Medical Personalized Medicine (PM) Solution Introduction
11.7.4 Astarte Medical Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.7.5 Astarte Medical Recent Developments
11.8 Fabric Genomics, INC.
11.8.1 Fabric Genomics, INC. Company Details
11.8.2 Fabric Genomics, INC. Business Overview
11.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Introduction
11.8.4 Fabric Genomics, INC. Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.8.5 Fabric Genomics, INC. Recent Developments
11.9 Orion Health
11.9.1 Orion Health Company Details
11.9.2 Orion Health Business Overview
11.9.3 Orion Health Personalized Medicine (PM) Solution Introduction
11.9.4 Orion Health Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.9.5 Orion Health Recent Developments
11.10 2B Precise
11.10.1 2B Precise Company Details
11.10.2 2B Precise Business Overview
11.10.3 2B Precise Personalized Medicine (PM) Solution Introduction
11.10.4 2B Precise Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.10.5 2B Precise Recent Developments
11.11 Fabric Genomics
11.11.1 Fabric Genomics Company Details
11.11.2 Fabric Genomics Business Overview
11.11.3 Fabric Genomics Personalized Medicine (PM) Solution Introduction
11.11.4 Fabric Genomics Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.11.5 Fabric Genomics Recent Developments
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Personalized Medicine (PM) Solution Introduction
11.12.4 Pfizer Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.12.5 Pfizer Recent Developments
11.13 Gene 42
11.13.1 Gene 42 Company Details
11.13.2 Gene 42 Business Overview
11.13.3 Gene 42 Personalized Medicine (PM) Solution Introduction
11.13.4 Gene 42 Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.13.5 Gene 42 Recent Developments
11.14 IBM Watson Health
11.14.1 IBM Watson Health Company Details
11.14.2 IBM Watson Health Business Overview
11.14.3 IBM Watson Health Personalized Medicine (PM) Solution Introduction
11.14.4 IBM Watson Health Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.14.5 IBM Watson Health Recent Developments
11.15 Philips Healthcare
11.15.1 Philips Healthcare Company Details
11.15.2 Philips Healthcare Business Overview
11.15.3 Philips Healthcare Personalized Medicine (PM) Solution Introduction
11.15.4 Philips Healthcare Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.15.5 Philips Healthcare Recent Developments
11.16 Medtronic
11.16.1 Medtronic Company Details
11.16.2 Medtronic Business Overview
11.16.3 Medtronic Personalized Medicine (PM) Solution Introduction
11.16.4 Medtronic Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.16.5 Medtronic Recent Developments
11.17 Nanthealth
11.17.1 Nanthealth Company Details
11.17.2 Nanthealth Business Overview
11.17.3 Nanthealth Personalized Medicine (PM) Solution Introduction
11.17.4 Nanthealth Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.17.5 Nanthealth Recent Developments
11.18 Navican
11.18.1 Navican Company Details
11.18.2 Navican Business Overview
11.18.3 Navican Personalized Medicine (PM) Solution Introduction
11.18.4 Navican Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.18.5 Navican Recent Developments
11.19 N-of-One
11.19.1 N-of-One Company Details
11.19.2 N-of-One Business Overview
11.19.3 N-of-One Personalized Medicine (PM) Solution Introduction
11.19.4 N-of-One Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.19.5 N-of-One Recent Developments
11.20 PierianDx
11.20.1 PierianDx Company Details
11.20.2 PierianDx Business Overview
11.20.3 PierianDx Personalized Medicine (PM) Solution Introduction
11.20.4 PierianDx Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.20.5 PierianDx Recent Developments
11.21 Sunquest Information System
11.21.1 Sunquest Information System Company Details
11.21.2 Sunquest Information System Business Overview
11.21.3 Sunquest Information System Personalized Medicine (PM) Solution Introduction
11.21.4 Sunquest Information System Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.21.5 Sunquest Information System Recent Developments
11.22 Tempus
11.22.1 Tempus Company Details
11.22.2 Tempus Business Overview
11.22.3 Tempus Personalized Medicine (PM) Solution Introduction
11.22.4 Tempus Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.22.5 Tempus Recent Developments
11.23 Novartis
11.23.1 Novartis Company Details
11.23.2 Novartis Business Overview
11.23.3 Novartis Personalized Medicine (PM) Solution Introduction
11.23.4 Novartis Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.23.5 Novartis Recent Developments
11.24 Translational Software
11.24.1 Translational Software Company Details
11.24.2 Translational Software Business Overview
11.24.3 Translational Software Personalized Medicine (PM) Solution Introduction
11.24.4 Translational Software Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.24.5 Translational Software Recent Developments
11.25 Biocrates Life Sciences AG
11.25.1 Biocrates Life Sciences AG Company Details
11.25.2 Biocrates Life Sciences AG Business Overview
11.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Introduction
11.25.4 Biocrates Life Sciences AG Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.25.5 Biocrates Life Sciences AG Recent Developments
11.26 Nanostring Technologies
11.26.1 Nanostring Technologies Company Details
11.26.2 Nanostring Technologies Business Overview
11.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Introduction
11.26.4 Nanostring Technologies Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.26.5 Nanostring Technologies Recent Developments
11.27 Thermo Fisher Scientific
11.27.1 Thermo Fisher Scientific Company Details
11.27.2 Thermo Fisher Scientific Business Overview
11.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Introduction
11.27.4 Thermo Fisher Scientific Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.27.5 Thermo Fisher Scientific Recent Developments
11.28 Quest Diagnostics Incorporated
11.28.1 Quest Diagnostics Incorporated Company Details
11.28.2 Quest Diagnostics Incorporated Business Overview
11.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Introduction
11.28.4 Quest Diagnostics Incorporated Revenue in Personalized Medicine (PM) Solution Business (2019-2024)
11.28.5 Quest Diagnostics Incorporated Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Personalized Medicine (PM) Solution was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 166
USD 3950.00
(Single User License)
The global Personalized Medicine (PM) Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 162
USD 2900.00
(Single User License)
The global Personalized Medicine (PM) Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-25
Pages: 182
USD 4900.00
(Single User License)
The global Personalized Medicine (PM) Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 126
USD 4250.00
(Single User License)
The global market for Personalized Medicine (PM) Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 166
USD 3950.00
(Single User License)
The global market for Personalized Medicine (PM) Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 120
USD 2900.00
(Single User License)
The global market for Personalized Medicine (PM) Solution was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-21
Pages: 172
USD 3950.00
(Single User License)
The global Personalized Medicine (PM) Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-10
Pages: 102
USD 2900.00
(Single User License)
The global market for Personalized Medicine (PM) Solution was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 166
The global Personalized Medicine (PM) Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 162
The global Personalized Medicine (PM) Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-25
Pages: 182
The global Personalized Medicine (PM) Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 126
The global market for Personalized Medicine (PM) Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 166
The global market for Personalized Medicine (PM) Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 120
The global market for Personalized Medicine (PM) Solution was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-21
Pages: 172
The global Personalized Medicine (PM) Solution market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-10
Pages: 102
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now